Your browser doesn't support javascript.
loading
Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis.
Gensicke, H; Frih, A A; Strbian, D; Zini, A; Pezzini, A; Padjen, V; Haueter, M; Seiffge, D J; Mäkitie, L; Traenka, C; Poli, L; Martinez-Majander, N; Putaala, J; Bonati, L H; Sibolt, G; Giovannini, G; Curtze, S; Beslac-Bumbasirevic, L; Vandelli, L; Lyrer, P A; Nederkoorn, P J; Tatlisumak, T; Engelter, S T.
Affiliation
  • Gensicke H; Stroke Center and Neurology, University Hospital Basel, Basel, Switzerland.
  • Frih AA; Stroke Center and Neurology, University Hospital Basel, Basel, Switzerland.
  • Strbian D; Clinical Neurosciences, Neurology, University of Helsinki, and Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
  • Zini A; Stroke Unit, Department of Neuroscience, Nuovo Ospedale Civile S. Agostino-Estense, AUSL Modena, Modena, Italy.
  • Pezzini A; Department of Clinical and Experimental Sciences, Neurology Clinic, University of Brescia, Modena, Italy.
  • Padjen V; Neurology Clinic, Clinical Centre of Serbia, Beograd, Serbia.
  • Haueter M; Stroke Center and Neurology, University Hospital Basel, Basel, Switzerland.
  • Seiffge DJ; Neurorehabilitation Unit, Felix Platter Hospital, University of Basel and University Center for Medicine of Aging, Basel, Switzerland.
  • Mäkitie L; Stroke Center and Neurology, University Hospital Basel, Basel, Switzerland.
  • Traenka C; Clinical Neurosciences, Neurology, University of Helsinki, and Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
  • Poli L; Stroke Center and Neurology, University Hospital Basel, Basel, Switzerland.
  • Martinez-Majander N; Department of Clinical and Experimental Sciences, Neurology Clinic, University of Brescia, Modena, Italy.
  • Putaala J; Clinical Neurosciences, Neurology, University of Helsinki, and Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
  • Bonati LH; Clinical Neurosciences, Neurology, University of Helsinki, and Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
  • Sibolt G; Stroke Center and Neurology, University Hospital Basel, Basel, Switzerland.
  • Giovannini G; Clinical Neurosciences, Neurology, University of Helsinki, and Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
  • Curtze S; Stroke Unit, Department of Neuroscience, Nuovo Ospedale Civile S. Agostino-Estense, AUSL Modena, Modena, Italy.
  • Beslac-Bumbasirevic L; Clinical Neurosciences, Neurology, University of Helsinki, and Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
  • Vandelli L; Neurology Clinic, Clinical Centre of Serbia, Beograd, Serbia.
  • Lyrer PA; Stroke Unit, Department of Neuroscience, Nuovo Ospedale Civile S. Agostino-Estense, AUSL Modena, Modena, Italy.
  • Nederkoorn PJ; Stroke Center and Neurology, University Hospital Basel, Basel, Switzerland.
  • Tatlisumak T; Department of Neurology, Academic Medical Center Amsterdam, The Netherlands.
  • Engelter ST; Clinical Neurosciences, Neurology, University of Helsinki, and Department of Neurology, Helsinki University Hospital, Helsinki, Finland.
Eur J Neurol ; 24(2): 262-269, 2017 02.
Article in En | MEDLINE | ID: mdl-27862667
ABSTRACT
BACKGROUND AND

PURPOSE:

Proteinuria and estimated glomerular filtration rate (eGFR) are indicators of renal function. Whether proteinuria better predicts outcome than eGFR in stroke patients treated with intravenous thrombolysis (IVT) remains to be determined.

METHODS:

In this explorative multicenter IVT register based study, the presence of urine dipstick proteinuria (yes/no), reduced eGFR (<60 ml/min/1.73 m2 ) and the coexistence of both with regard to (i) poor 3-month outcome (modified Rankin Scale score 3-6), (ii) death within 3 months and (iii) symptomatic intracranial hemorrhage (ECASS-II criteria) were compared. Unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals were calculated.

RESULTS:

Amongst 3398 patients, 881 (26.1%) had proteinuria and 623 (18.3%) reduced eGFR. Proteinuria [ORadjusted 1.65 (1.37-2.00) and ORadjusted 1.52 (1.24-1.88)] and reduced eGFR [ORadjusted 1.26 (1.01-1.57) and ORadjusted 1.34 (1.06-1.69)] were independently associated with poor functional outcome and death, respectively. After adding both renal markers to the models, proteinuria [ORadjusted+eGFR 1.59 (1.31-1.93)] still predicted poor outcome whilst reduced eGFR [ORadjusted+proteinuria 1.20 (0.96-1.50)] did not. Proteinuria was associated with symptomatic intracranial hemorrhage [ORadjusted 1.54 (1.09-2.17)] but not reduced eGFR [ORadjusted 0.96 (0.63-1.62)]. In 234 (6.9%) patients, proteinuria and reduced eGFR were coexistent. Such patients were at the highest risk of poor outcome [ORadjusted 2.16 (1.54-3.03)] and death [ORadjusted 2.55 (1.69-3.84)].

CONCLUSION:

Proteinuria and reduced eGFR were each independently associated with poor outcome and death but the statistically strongest association appeared for proteinuria. Patients with coexistent proteinuria and reduced eGFR were at the highest risk of poor outcome and death.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteinuria / Thrombolytic Therapy / Stroke / Intracranial Hemorrhages Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2017 Document type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteinuria / Thrombolytic Therapy / Stroke / Intracranial Hemorrhages Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2017 Document type: Article Affiliation country: Switzerland